STAT4 ‐dependent regulation of neuroinflammation in atherosclerosis
Physiological Reports · 2026-04 · 14 (7)
DOI: 10.14814/phy2.70856 ↗At a glance
Journal article in Physiological Reports, published online on 2026-04-06. Written by Natalie Stahr and 6 co-authors. Institution: Department of Biomedical and Translational Science, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion Univ…. Major MEDLINE topics: STAT4 Transcription Factor, Atherosclerosis, Neuroinflammatory Diseases. 62 references. The full text is freely available (open access, CC BY 4.0). Funded by: HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), American Heart Association (AHA), NIH HHS.
Abstract (original language)
Atherosclerosis is linked to an increased risk of cognitive decline, with chronic inflammation being a common feature of both pathologies. IL‐12 activates STAT4 to regulate myeloid cell functions, and blockade of this pathway alleviates cognitive impairment in Alzheimer's models. However, the mechanisms connecting vascular pathology to neuroinflammation remain unclear. Here, we examine whether STAT4 functions as a common mediator of neuroinflammation in atherosclerosis. We demonstrate that LysM Cre ‐specific STAT4 deficiency ameliorates deficits in long‐term memory in low‐density lipoprotein‐deficient ( Ldlr −/− ) mice fed a high‐fat diet (HFD‐C). STAT4 deficiency moderately reduces Ser199‐phosphorylated Tau burden. Atherosclerosis alters brain immune composition, characterized by increased numbers of CD45 + leukocytes, activated microglia, and activated T and B cells, whereas STAT4 deficiency attenuates these effects. Nanostring gene‐expression pathway analysis further highlights the importance of STAT4 in regulating multiple neuroinflammatory pathways and the Rhodopsin‐like receptor signaling, which is associated with synaptic plasticity. LysM Cre ‐specific STAT4 deficiency supports microglial efferocytosis in atherosclerotic Ldlr −/− mice and increases the number of efferocytotic macrophages. Accordingly, STAT4 deficiency also reduces neuronal death. Overall, our data reveal an important role for myeloid‐driven STAT4 expression in the pathogenesis of cognitive decline associated with atherosclerosis, mediated through impaired efferocytosis and enhanced leukocyte activation, leading to increased brain neuroinflammation.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biomedical and Translational Science, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia, USA.
- Center for Integrative Neuroscience and Inflammatory Diseases, Eastern Virginia Medical School, Macon & Joan Brock Virginia Health Sciences at Old Dominion University, Norfolk, Virginia, USA.
- Division of Microbiology, Department of Microbiology, Tulane National Primate Research Center, Covington, Louisiana, USA.
- Department of Microbiology & Immunology, Tulane University School of Medicine, New Orleans, Louisiana, USA.
ORCID profiles: Elena V Galkina
Funding
- HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)
- American Heart Association (AHA)
- NIH HHS
- National Heart, Lung, and Blood Institute
Cite
APA
Stahr, N., Moriarty, A. K., Ma, S. D., Keeter, W. C., Kim, W. K., Sanford, L. D., & Galkina, E. V. (2026). STAT4 ‐dependent regulation of neuroinflammation in atherosclerosis. Physiological Reports, 14(7). https://doi.org/10.14814/phy2.70856
Vancouver
Stahr N, Moriarty AK, Ma SD, Keeter WC, Kim WK, Sanford LD, et al. STAT4 ‐dependent regulation of neuroinflammation in atherosclerosis. Physiological Reports. 2026;14(7). doi:10.14814/phy2.70856
BibTeX
@article{Stahr2026,
author = {Stahr, Natalie and Moriarty, Alina K and Ma, Shelby D and Keeter, W Coles and Kim, Woong-Ki and Sanford, Larry D and Galkina, Elena V},
title = {STAT4 ‐dependent regulation of neuroinflammation in atherosclerosis},
journal = {Physiological Reports},
year = {2026},
volume = {14},
number = {7},
doi = {10.14814/phy2.70856}
}
EUVIMED